PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Nuestra Señora de Candelaria (17)
2024
2023
-
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 1, pp. 57-64
-
Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage
Actas Dermo-Sifiliograficas
-
Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 4, pp. 291-298
2022
-
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial
The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433
-
EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: Real-world data in Spanish patients (MICADOS Study)
JEADV Clinical Practice, Vol. 1, Núm. 4, pp. 438-449
2021
-
EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: real-world data in Spanish patients (MICADOS study)
European Journal of Cancer, Vol. 156, pp. S29-S30
-
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the European Academy of Dermatology and Venereology
2020
-
Cost of early-stage mycosis fungoides treatments in Spain
ClinicoEconomics and Outcomes Research, Vol. 12, pp. 91-105
-
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 4, pp. 762-768
-
Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
Journal of the American Academy of Dermatology, Vol. 83, Núm. 5, pp. 1535-1538
2018
-
Association of APOA5 and APOC3 Genetic Polymorphisms with Severity of Hypertriglyceridemia in Patients with Cutaneous T-Cell Lymphoma Treated with Bexarotene
JAMA Dermatology, Vol. 154, Núm. 12, pp. 1424-1431
-
First-line treatment in lymphomatoid papulosis: a retrospective multicentre study
Clinical and Experimental Dermatology, Vol. 43, Núm. 2, pp. 137-143
-
The First Year of the AEVD Primary Cutaneous Lymphoma Registry
Actas Dermo-Sifiliograficas, Vol. 109, Núm. 7, pp. 610-616
2014
-
Rituximab in the treatment of primary cutaneous B-cell lymphoma: A review
Actas Dermo-Sifiliograficas
2013
-
MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma
Modern Pathology, Vol. 26, Núm. 2, pp. 171-181
2012
-
Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: An epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma
British Journal of Dermatology, Vol. 167, Núm. 1, pp. 174-179